# terazosin

NDC: 68788-8171
Generic name: terazosin
Labeler / Manufacturer: Preferred Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20220425

FDA application: ANDA075614

## Active ingredients

- TERAZOSIN HYDROCHLORIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68788-8171"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68788-8171
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a78f74ce-1c53-41ea-878e-13674db10a67
